Hottest Stocks (Over $10)	Hottest Stocks ($2-$10)	Biggest Losers (Over $10)	Biggest Losers ($2-$10)	Hottest Industries	Hottest Sectors	EPS / Sales Surprises
Enter Ticker Symbol:   Ticker Lookup Company Quote Company Profile Research Summary EPS Consensus Perspective Insider Transactions Price Performance

Enter any portion of the company’s name to find its corresponding ticker symbol:

Search for :

Zacks Company Profile for Bausch + Lomb Corporation (BLCO : NYSE)

• Company Description    Bausch Lomb Corporation is an eye health company. Its product portfolio includes Biotrue(R) and renu(R) multi-purpose solutions, Biotrue(R) ONEday daily disposable contact lenses, LUMIFY(R) redness reliever eye drops, PreserVision(R) AREDS 2 formula eye vitamin and mineral supplements and VYZULTA(R). Bausch Lomb Corporation is based in VAUGHAN, ON. Number of Employees: 13,000

• Price / Volume Information    Yesterday's Closing Price: $17.11 Daily Weekly Monthly 20 Day Moving Average: 330,725 shares Shares Outstanding: 357.35 (millions) Market Capitalization: $6,114.31 (millions) Beta: 0.56 52 Week High: $18.92 52 Week Low: $13.77 Short Interest Ratio:   % Price Change % Price Change Relative to S&P 500 4 Week -5.16% -5.21% 12 Week 5.42% 3.41% Year To Date 0.18% -11.20%

• Address & Contact Information Street Address Phone / Fax Email Address Web URL 520 APPLEWOOD CRESCENT - VAUGHAN,A6 L4K 4B4 CAN ph: 905-695-7700 fax: - None http://www.bausch.com

• General Corporate Information    Officers Brenton L. Saunders - Chairman of the Board and Chief Executive Officer Sam Eldessouky - Executive Vice President and Chief Financial Offic Frederick J. Munsch - Senior Vice President; Controller and Chief Accoun Eduardo Alfonso - Director Nathalie Bernier - Director Peer Information Bausch + Lomb Corporation (CHCR) Bausch + Lomb Corporation (ESRX) Bausch + Lomb Corporation (MYDP) Bausch + Lomb Corporation (COR) Bausch + Lomb Corporation (GBCS) Bausch + Lomb Corporation (LAXAF) Industry / Sector / Ticker Info Analyst Coverage: No Industry Group: Medical Services Sector: Medical CUSIP: 071705107 SIC: 3851 Fiscal Year Fiscal Year End: December Last Reported Quarter: 06/01/26 Next Expected EPS Date: 11/04/26 Share - Related Items Shares Outstanding: 357.35 Most Recent Split Date: (:1) Beta: 0.56 Market Capitalization: $6,114.31 (millions)

• EPS Information     • Dividend Information Analyst Coverage: No Dividend Yield: 0.00% Current Fiscal Quarter EPS Consensus Estimate: $0.33 Indicated Annual Dividend: $0.00 Current Fiscal Year EPS Consensus Estimate: $0.81 Payout Ratio: 0.00 Number of Estimates in the Fiscal Year Consensus: 4.00 Change In Payout Ratio: 0.00 Estmated Long-Term EPS Growth Rate: 39.44% Last Dividend Paid: NA - $0.00 Next EPS Report Date: 11/04/26

• Fundamental Ratios P/E Current FY Estimate: 21.20 Trailing 12 Months: 23.12 PEG Ratio: 0.54 Price Ratios Price/Book: 0.95 Price/Cash Flow: 10.26 Price / Sales: 1.15 EPS Growth vs. Year Ago Period: 128.57% vs. Previous Quarter: 100.00% Sales Growth vs. Year Ago Period: 9.08% vs. Previous Quarter: 12.06% ROE 09/30/26 - - 06/30/26 - 4.14 03/31/26 - 3.60 ROA 09/30/26 - - 06/30/26 - 1.93 03/31/26 - 1.69 Current Ratio 09/30/26 - - 06/30/26 - 1.55 03/31/26 - 1.53 Quick Ratio 09/30/26 - - 06/30/26 - 1.02 03/31/26 - 0.99 Operating Margin 09/30/26 - - 06/30/26 - 5.03 03/31/26 - 4.49 Net Margin 09/30/26 - - 06/30/26 - -3.21 03/31/26 - -4.21 Pre-Tax Margin 09/30/26 - - 06/30/26 - -1.22 03/31/26 - -3.86 Book Value 09/30/26 - - 06/30/26 - 18.05 03/31/26 - 18.10 Inventory Turnover 09/30/26 - - 06/30/26 - 2.08 03/31/26 - 2.05 Debt-to-Equity 09/30/26 - - 06/30/26 - 0.79 03/31/26 - 0.78 Debt-to-Capital 09/30/26 - - 06/30/26 - 44.04 03/31/26 - 43.81

Powered by Zacks Investment Research ©